Search
In patients with type 2 diabetes and CV disease, empagliflozin ...
An industry-funded trial found that those who took empagliflozin had lower rates of mortality, including from cardiovascular (CV) events, than those on ...
Safety of dipeptidyl peptidase-4 inhibitors analyzed in 2 ...
A meta-analysis of dipeptidyl peptidase-4 inhibitors showed no increase in pancreatic adverse events, while a trial of saxagliptin found no effect on the ...
Gastric bypass or biliopancreatic diversion increases ...
A randomized controlled trial (RCT) of 60 severely obese adults with type 2 diabetes found that gastric bypass or biliopancreatic diversion increased ...
An intensive lifestyle intervention increased remission from ...
In the randomized, controlled Look AHEAD trial, an intensive lifestyle intervention (ILI) was associated with partial remission of type 2 diabetes when ...
Review: Dapagliflozin increases, and empagliflozin reduces ...
A commentary called for the findings to be confirmed with randomized controlled trials designed specifically to evaluate the effect of SGLT2 inhibitors ...
Review: Metformin is linked to reduced mortality in type 2 ...
The included studies focused on metformin use in patients with chronic kidney disease (CKD), congestive heart failure (CHF), chronic liver disease (CLD ...
In patients with type 2 diabetes and high CV risk, liraglutide ...
The study's primary composite outcome was first occurrence of death from cardiovascular (CV) causes, nonfatal (including silent) myocardial infarction ...
Review: Type 2 diabetes screening does not reduce mortality ...
A systematic evidence review by the US Preventive Services Task Force found no evidence of mortality benefit from screening for diabetes, based on ...
Review: In adult outpatients, nurse-managed protocols ...
Medication titration by nurses according to protocols was associated with a modest improvement in control of some chronic diseases, including diabetes ...
In abstinent adults with type 2 diabetes, a daily glass of wine ...
Drinking red wine, rather than mineral water, with dinner every night for 2 years was associated with improvements in cholesterol markers in patients ...